177 related articles for article (PubMed ID: 27166395)
21. Visualization and characterization of cancer stem-like cells in cervical cancer.
Hayashi K; Tamari K; Ishii H; Konno M; Nishida N; Kawamoto K; Koseki J; Fukusumi T; Kano Y; Nishikawa S; Miyo M; Noguchi K; Ogawa H; Hamabe A; Seo Y; Doki Y; Mori M; Ogawa K
Int J Oncol; 2014 Dec; 45(6):2468-74. PubMed ID: 25269542
[TBL] [Abstract][Full Text] [Related]
22. Chronic chemotherapeutic stress promotes evolution of stemness and WNT/beta-catenin signaling in colorectal cancer cells: implications for clinical use of WNT-signaling inhibitors.
Ayadi M; Bouygues A; Ouaret D; Ferrand N; Chouaib S; Thiery JP; Muchardt C; Sabbah M; Larsen AK
Oncotarget; 2015 Jul; 6(21):18518-33. PubMed ID: 26041882
[TBL] [Abstract][Full Text] [Related]
23. SCGB2A1 is a novel prognostic marker for colorectal cancer associated with chemoresistance and radioresistance.
Munakata K; Uemura M; Takemasa I; Ozaki M; Konno M; Nishimura J; Hata T; Mizushima T; Haraguchi N; Noura S; Ikenaga M; Okamura S; Fukunaga M; Murata K; Yamamoto H; Doki Y; Mori M
Int J Oncol; 2014 May; 44(5):1521-8. PubMed ID: 24585249
[TBL] [Abstract][Full Text] [Related]
24. Novel therapeutic diiminoquinone exhibits anticancer effects on human colorectal cancer cells in two-dimensional and three-dimensional
Monzer A; Wakimian K; Ballout F; Al Bitar S; Yehya A; Kanso M; Saheb N; Tawil A; Doughan S; Hussein M; Mukherji D; Faraj W; Gali-Muhtasib H; Abou-Kheir W
World J Gastroenterol; 2022 Sep; 28(33):4787-4811. PubMed ID: 36156922
[TBL] [Abstract][Full Text] [Related]
25. Significance of mTOR signaling and its inhibitor against cancer stem-like cells in colorectal cancer.
Cai Z; Ke J; He X; Yuan R; Chen Y; Wu X; Wang L; Wang J; Lan P; Wu X
Ann Surg Oncol; 2014 Jan; 21(1):179-88. PubMed ID: 23907312
[TBL] [Abstract][Full Text] [Related]
26. Visualization of stem cell features in human hepatocellular carcinoma reveals in vivo significance of tumor-host interaction and clinical course.
Muramatsu S; Tanaka S; Mogushi K; Adikrisna R; Aihara A; Ban D; Ochiai T; Irie T; Kudo A; Nakamura N; Nakayama K; Tanaka H; Yamaoka S; Arii S
Hepatology; 2013 Jul; 58(1):218-28. PubMed ID: 23447025
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of the circadian clock gene Bmal1 increases sensitivity to oxaliplatin in colorectal cancer.
Zeng ZL; Luo HY; Yang J; Wu WJ; Chen DL; Huang P; Xu RH
Clin Cancer Res; 2014 Feb; 20(4):1042-52. PubMed ID: 24277452
[TBL] [Abstract][Full Text] [Related]
28. Characterization of side population cells isolated from the colon cancer cell line SW480.
Xiong B; Ma L; Hu X; Zhang C; Cheng Y
Int J Oncol; 2014 Sep; 45(3):1175-83. PubMed ID: 24926880
[TBL] [Abstract][Full Text] [Related]
29. Establishment of a human colorectal cancer cell line P6C with stem cell properties and resistance to chemotherapeutic drugs.
Rao GH; Liu HM; Li BW; Hao JJ; Yang YL; Wang MR; Wang XH; Wang J; Jin HJ; Du L; Chen Q
Acta Pharmacol Sin; 2013 Jun; 34(6):793-804. PubMed ID: 23736004
[TBL] [Abstract][Full Text] [Related]
30. Identification and Characterization of CD107a as a Marker of Low Reactive Oxygen Species in Chemoresistant Cells in Colorectal Cancer.
Kitahara T; Haraguchi N; Takahashi H; Nishimura J; Hata T; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M
Ann Surg Oncol; 2017 Apr; 24(4):1110-1119. PubMed ID: 27834032
[TBL] [Abstract][Full Text] [Related]
31. Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer.
Toden S; Tran HM; Tovar-Camargo OA; Okugawa Y; Goel A
Oncotarget; 2016 Mar; 7(13):16158-71. PubMed ID: 26930714
[TBL] [Abstract][Full Text] [Related]
32. Pien Tze Huang inhibits the proliferation, and induces the apoptosis and differentiation of colorectal cancer stem cells via suppression of the Notch1 pathway.
Qi F; Wei L; Shen A; Chen Y; Lin J; Chu J; Cai Q; Pan J; Peng J
Oncol Rep; 2016 Jan; 35(1):511-7. PubMed ID: 26530025
[TBL] [Abstract][Full Text] [Related]
33. STRAP Promotes Stemness of Human Colorectal Cancer via Epigenetic Regulation of the NOTCH Pathway.
Jin L; Vu T; Yuan G; Datta PK
Cancer Res; 2017 Oct; 77(20):5464-5478. PubMed ID: 28827371
[TBL] [Abstract][Full Text] [Related]
34. Exosomal Wnt-induced dedifferentiation of colorectal cancer cells contributes to chemotherapy resistance.
Hu YB; Yan C; Mu L; Mi YL; Zhao H; Hu H; Li XL; Tao DD; Wu YQ; Gong JP; Qin JC
Oncogene; 2019 Mar; 38(11):1951-1965. PubMed ID: 30390075
[TBL] [Abstract][Full Text] [Related]
35. E-cadherin-Fc chimera protein matrix enhances cancer stem-like properties and induces mesenchymal features in colon cancer cells.
Qian Y; Wu X; Yokoyama Y; Okuzaki D; Taguchi M; Hirose H; Wang J; Hata T; Inoue A; Hiraki M; Ohtsuka M; Takahashi H; Haraguchi N; Mizushima T; Tanaka S; Mori M; Yamamoto H
Cancer Sci; 2019 Nov; 110(11):3520-3532. PubMed ID: 31505062
[TBL] [Abstract][Full Text] [Related]
36. SSEA-3 as a novel amplifying cancer cell surface marker in colorectal cancers.
Suzuki Y; Haraguchi N; Takahashi H; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Ishii H; Doki Y; Mori M; Yamamoto H
Int J Oncol; 2013 Jan; 42(1):161-7. PubMed ID: 23175153
[TBL] [Abstract][Full Text] [Related]
37. Primary cultures of human colon cancer as a model to study cancer stem cells.
Koshkin S; Danilova A; Raskin G; Petrov N; Bajenova O; O'Brien SJ; Tomilin A; Tolkunova E
Tumour Biol; 2016 Sep; 37(9):12833-12842. PubMed ID: 27449036
[TBL] [Abstract][Full Text] [Related]
38. Chemoresistant colorectal cancer cells and cancer stem cells mediate growth and survival of bystander cells.
Bose D; Zimmerman LJ; Pierobon M; Petricoin E; Tozzi F; Parikh A; Fan F; Dallas N; Xia L; Gaur P; Samuel S; Liebler DC; Ellis LM
Br J Cancer; 2011 Nov; 105(11):1759-67. PubMed ID: 22045189
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of colorectal cancer stem cell survival and invasive potential by hsa-miR-140-5p mediated suppression of Smad2 and autophagy.
Zhai H; Fesler A; Ba Y; Wu S; Ju J
Oncotarget; 2015 Aug; 6(23):19735-46. PubMed ID: 25980495
[TBL] [Abstract][Full Text] [Related]
40. SW480 colorectal cancer cells that naturally express Lgr5 are more sensitive to the most common chemotherapeutic agents than Lgr5-negative SW480 cells.
Planutis AK; Holcombe RF; Planoutene MV; Planoutis KS
Anticancer Drugs; 2015 Oct; 26(9):942-7. PubMed ID: 26196680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]